View in EDS

Safety and Tolerability of Ruxolitinib Cream in Adolescents with Mild-to-Moderate Atopic Dermatitis: Results From a 1-Year, Phase III, Open-Label Study.

Saved in:
Bibliographic Details
Title: Safety and Tolerability of Ruxolitinib Cream in Adolescents with Mild-to-Moderate Atopic Dermatitis: Results From a 1-Year, Phase III, Open-Label Study.
Authors: Joyce JC; Division of Dermatology, Department of Medicine, Endeavor Health, 9933 Woods Drive, Suite 100, Skokie, IL, 60077, USA. joel.joyce@endeavorhealth.org., Hong HC; Department of Dermatology and Skin Science, University of British Columbia, Vancouver, BC, Canada.; Probity Medical Research, Surrey, BC, Canada., Siri DD; Sneeze, Wheeze, and Itch Clinical Research Center, Normal, IL, USA., Toth D; Probity Medical Research, Windsor, ON, Canada., Kallender H; Incyte Corporation, Wilmington, DE, USA., Kuo Y; Incyte Corporation, Wilmington, DE, USA., Stefani-Hunyady D; Incyte Corporation, Wilmington, DE, USA., Papp KA; Probity Medical Research, Waterloo, ON, Canada.; Division of Dermatology, Temerty Faculty of Medicine, University of Toronto, Toronto, ON, Canada.; Alliance Clinical Trials, Waterloo, ON, Canada.
Source: American journal of clinical dermatology [Am J Clin Dermatol] 2026 Jul; Vol. 27 (4), pp. 841-849. Date of Electronic Publication: 2026 May 27.
Publication Type: Journal Article; Clinical Trial, Phase III; Multicenter Study
Journal Info: Publisher: Adis, Springer International Country of Publication: New Zealand NLM ID: 100895290 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1179-1888 (Electronic) Linking ISSN: 11750561 NLM ISO Abbreviation: Am J Clin Dermatol Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 42201487
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Safety and Tolerability of Ruxolitinib Cream in Adolescents with Mild-to-Moderate Atopic Dermatitis: Results From a 1-Year, Phase III, Open-Label Study.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Joyce+JC%22">Joyce JC</searchLink>; Division of Dermatology, Department of Medicine, Endeavor Health, 9933 Woods Drive, Suite 100, Skokie, IL, 60077, USA. joel.joyce@endeavorhealth.org.<br /><searchLink fieldCode="AU" term="%22Hong+HC%22">Hong HC</searchLink>; Department of Dermatology and Skin Science, University of British Columbia, Vancouver, BC, Canada.; Probity Medical Research, Surrey, BC, Canada.<br /><searchLink fieldCode="AU" term="%22Siri+DD%22">Siri DD</searchLink>; Sneeze, Wheeze, and Itch Clinical Research Center, Normal, IL, USA.<br /><searchLink fieldCode="AU" term="%22Toth+D%22">Toth D</searchLink>; Probity Medical Research, Windsor, ON, Canada.<br /><searchLink fieldCode="AU" term="%22Kallender+H%22">Kallender H</searchLink>; Incyte Corporation, Wilmington, DE, USA.<br /><searchLink fieldCode="AU" term="%22Kuo+Y%22">Kuo Y</searchLink>; Incyte Corporation, Wilmington, DE, USA.<br /><searchLink fieldCode="AU" term="%22Stefani-Hunyady+D%22">Stefani-Hunyady D</searchLink>; Incyte Corporation, Wilmington, DE, USA.<br /><searchLink fieldCode="AU" term="%22Papp+KA%22">Papp KA</searchLink>; Probity Medical Research, Waterloo, ON, Canada.; Division of Dermatology, Temerty Faculty of Medicine, University of Toronto, Toronto, ON, Canada.; Alliance Clinical Trials, Waterloo, ON, Canada.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22100895290%22">American journal of clinical dermatology</searchLink> [Am J Clin Dermatol] 2026 Jul; Vol. 27 (4), pp. 841-849. <i>Date of Electronic Publication: </i>2026 May 27.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Clinical Trial, Phase III; Multicenter Study
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Adis%2C+Springer+International%22">Adis, Springer International </searchLink><i>Country of Publication: </i>New Zealand <i>NLM ID: </i>100895290 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1179-1888 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2211750561%22">11750561 </searchLink><i>NLM ISO Abbreviation: </i>Am J Clin Dermatol <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=42201487
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1007/s40257-026-01043-0
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 841
    Titles:
      – TitleFull: Safety and Tolerability of Ruxolitinib Cream in Adolescents with Mild-to-Moderate Atopic Dermatitis: Results From a 1-Year, Phase III, Open-Label Study.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Joyce JC
      – PersonEntity:
          Name:
            NameFull: Hong HC
      – PersonEntity:
          Name:
            NameFull: Siri DD
      – PersonEntity:
          Name:
            NameFull: Toth D
      – PersonEntity:
          Name:
            NameFull: Kallender H
      – PersonEntity:
          Name:
            NameFull: Kuo Y
      – PersonEntity:
          Name:
            NameFull: Stefani-Hunyady D
      – PersonEntity:
          Name:
            NameFull: Papp KA
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 07
              Text: 2026 Jul
              Type: published
              Y: 2026
          Identifiers:
            – Type: issn-electronic
              Value: 1179-1888
          Numbering:
            – Type: volume
              Value: 27
            – Type: issue
              Value: 4
          Titles:
            – TitleFull: American journal of clinical dermatology
              Type: main
ResultId 1